113.80

1.48% 1.90

Cardinal Health Inc (CAH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Cardinal Health Inc stock is traded at $113.80, with a volume of 685.59K. It is up +1.48% in the last 24 hours and up +1.41% over the past month. Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and McKesson, the three comprise well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Previous Close:

$111.90

Open:

$112.22

24h Volume:

685.59K

Relative Volume:

0.38

Market Cap:

$27.26B

Revenue:

$226.83B

Net Income/Loss:

$852.00M

P/E Ratio:

186.56

EPS:

0.61

Net Cash Flow:

$3.25B

1W Performance:

+3.18%

1M Performance:

+1.41%

6M Performance:

+14.81%

1Y Performance:

+13.32%

1-Day Range:

$110.63

$114.05

1-Week Range:

$106.98

$119.12

52-Week Range:

$93.17

$119.12

Cardinal Health Inc Stock (CAH) Company Profile

Name

Cardinal Health Inc

Sector

Healthcare (1181)

Industry

Medical Distribution (12)

Phone

(614) 757-3033

Address

7000 CARDINAL PLACE, DUBLIN, OH

Employee

48,000

Twitter

@cardinalhealth

Next Earnings Date

2024-11-01

Latest SEC Filings

CAH's Discussions on Twitter

Cardinal Health Inc Stock (CAH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Upgrade	Argus	Hold → Buy
Jan-03-24	Initiated	Barclays	Overweight
Dec-14-23	Initiated	Wells Fargo	Underweight
Jul-10-23	Downgrade	Evercore ISI	Outperform → In-line
Mar-31-23	Initiated	Citigroup	Neutral
Feb-03-23	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-04-22	Upgrade	BofA Securities	Underperform → Neutral
Aug-22-22	Resumed	Morgan Stanley	Overweight
May-26-22	Downgrade	Barclays	Overweight → Equal Weight
May-18-22	Upgrade	Evercore ISI	In-line → Outperform
Apr-12-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-01-22	Resumed	Credit Suisse	Neutral
Aug-06-21	Downgrade	Deutsche Bank	Buy → Hold
Aug-05-21	Downgrade	BofA Securities	Buy → Underperform
May-10-21	Downgrade	Robert W. Baird	Outperform → Neutral
Jan-08-21	Upgrade	Wolfe Research	Underperform → Peer Perform
Nov-02-20	Upgrade	Barclays	Equal Weight → Overweight
Sep-25-20	Upgrade	Deutsche Bank	Hold → Buy
Jul-20-20	Upgrade	Guggenheim	Neutral → Buy
May-15-20	Upgrade	UBS	Neutral → Buy
Apr-23-20	Resumed	Credit Suisse	Neutral
Mar-20-20	Upgrade	BofA/Merrill	Underperform → Buy
Feb-12-20	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform
Dec-16-19	Downgrade	Guggenheim	Buy → Neutral
Sep-12-19	Initiated	Deutsche Bank	Hold
Aug-27-19	Downgrade	Argus	Buy → Hold
Aug-20-19	Upgrade	Guggenheim	Neutral → Buy
Apr-18-19	Initiated	Guggenheim	Neutral
Jan-17-19	Initiated	UBS	Neutral
Nov-16-18	Downgrade	Leerink Partners	Outperform → Mkt Perform
Apr-24-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
Apr-02-18	Upgrade	Argus	Hold → Buy
Mar-08-18	Initiated	Barclays	Equal Weight
Feb-27-18	Resumed	BofA/Merrill	Underperform
Jan-05-18	Initiated	Evercore ISI	In-line

View All

Cardinal Health Inc Stock (CAH) Latest News

Nov 04, 2024

Officials rejects Dublin schools’ plan to buy Cardinal Health building for $37 million - MSN

Nov 04, 2024

Cardinal Health's SWOT analysis: stock outlook amid specialty push, GMPD challenges - Investing.com

Nov 04, 2024

Cardinal Health Q1 Earnings: Margins Signal More Upside (NYSE:CAH) - Seeking Alpha

Nov 04, 2024

Global Guidewires Market Poised for Significant Growth: Surge in Minimally Invasive Procedures and Technological Advancements Drive Market toward USD 6,885.7 million by 2034 | FMI - GlobeNewswire Inc.

Nov 04, 2024

T2 Biosystems Forges Sales Deal With Cardinal Health for Sepsis Test - MPO-mag

Nov 04, 2024